Posted on Leave a comment

Penis Envy Mushrooms: Effects, Benefits & Risks

penis envy mushroom

Penis Envy mushrooms, also known as Psilocybe Cubensis Penis Envy, are one of the most powerful strains of psilocybin mushroom. Penis envy mushrooms are grown from mushroom spores and are highly sought after for their potent effects. Here’s what you need to know about the effects, benefits and risks of these mushrooms.

Effects

Penis Envy mushrooms are known for their powerful psychoactive effects. They contain high levels of psilocybin, the active ingredient responsible for the hallucinogenic effects of magic mushrooms. As a result, users can expect intense and long-lasting trips that can last up to six hours.

Some users describe the effects of Penis Envy mushrooms as more intense than other types of magic mushrooms, with deeper visual distortions, a heavy body-feel, profound insights, and a more mystical quality. However, the subjective effects can vary depending on factors such as dosage, set, and setting.

Benefits

  1. Treatment of Depression and Anxiety: Psilocybin has been shown to have a positive effect on individuals with depression and anxiety. In a study published in the Journal of Psychopharmacology, researchers found that psilocybin-assisted therapy significantly reduced symptoms of depression and anxiety in patients with life-threatening cancer.
  2. Addiction Treatment: Studies have shown that psilocybin-assisted therapy can be effective in treating addiction to substances such as alcohol and nicotine. A small study published in the Journal of Psychopharmacology found that psilocybin-assisted therapy resulted in abstinence from smoking in 80% of participants at a six-month follow-up.
  3. Improved Creativity and Problem-Solving: Some users of psilocybin report enhanced creativity and problem-solving abilities. A study published in the journal Translational Psychiatry found that psilocybin enhanced creative thinking and cognitive flexibility in healthy volunteers.
  4. Spiritual and Existential Experiences: Many individuals report having spiritual or existential experiences while under the influence of psilocybin. A study published in the Journal of Psychopharmacology found that psilocybin-assisted therapy resulted in significant increases in mystical-type experiences and overall well-being.
  5. Palliative Care: Psilocybin-assisted therapy has shown promise in helping individuals with life-threatening illnesses cope with their condition. A study published in the Journal of Psychopharmacology found that psilocybin-assisted therapy resulted in significant reductions in anxiety and depression in patients with life-threatening cancer.

Risks

As with any psychedelic substance, there are some risks associated with taking Penis Envy mushrooms. These include:

  1. Bad trips: Some users may experience a bad trip, which can involve feelings of anxiety, fear, or paranoia. These experiences can be particularly distressing when using potent mushrooms like Penis Envy. To reduce this risk, always make sure you are in a good mental state and also a good physical setting.
  1. HPPD: Hallucinogen Persisting Perception Disorder (HPPD) is a rare but possible long-term side effect of psychedelic use. It can result in persistent changes in visual perception, such as seeing halos, trails, or flashes of light, long after the drug has worn off.
  2. Personal safety: Taking any psychedelic substance can impair judgment and increase the risk of accidents or injuries. It’s important to take precautions and avoid driving or operating heavy machinery while under the influence.

It is important to note that the possession and use of Penis Envy mushrooms, and other magic mushrooms, is illegal in many countries. Additionally, the effects of magic mushrooms can vary greatly depending on the individual and their set and setting, so it is important to use caution and start with a low dose when trying them for the first time.

In conclusion, Penis Envy mushrooms are a potent strain of magic mushrooms known for their psychoactive effects and documented therapeutic benefits. However, their use is illegal in many countries, and caution should be exercised when trying them for the first time.

ape revert mushrooms

Sources

“Psilocybin Mushrooms” by Drug Enforcement Administration: https://www.dea.gov/factsheets/psilocybin-mushrooms

“Psilocybin Mushrooms of the World: An Identification Guide” by Paul Stamets

“Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial” by Alan K. Davis et al. in JAMA Psychiatry

“Psilocybin-assisted therapy: a review of a novel treatment for psychiatric disorders” by Alicia Danforth and Charles Grob in Journal of Psychoactive Drugs

“Hallucinogen Persisting Perception Disorder (HPPD)” by National Institute on Drug Abuse: https://www.drugabuse.gov/publications/drugfacts/hallucinogens

“The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead” by Timothy Leary, Ralph Metzner, and Richard Alpert.

  1. Top of Form

Grob, C. S., et al. “Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.” Journal of psychopharmacology 22.6 (2008): 621-632.

Johnson, M. W., et al. “Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.” Journal of psychopharmacology 28.11 (2014): 983-992.

Kaelen, M., et al. “The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.” Frontiers in human neuroscience 8 (2014): 20.

Griffiths, R. R., et al. “Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.” Psychopharmacology 187.3 (2006): 268-283.

Ross, S., et al. “Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.” Journal of Psychopharmacology 30.12 (2016): 1165-1180.

Carhart-Harris, R. L., et al. “The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.” Frontiers in human neuroscience 8 (2014): 20.

Leave a Reply